Who owns the DELIVEREX trademark?

The DELIVEREX trademark is owned by Evox Therapeutics Limited.

What is the serial number for DELIVEREX?

The USPTO serial number for DELIVEREX is 79282940.

What is the registration number for DELIVEREX?

DELIVEREX is registered under USPTO registration number 6405652.

DEL

USPTO Trademark Record

REGISTERED

DELIVEREX

Q: What class is the DELIVEREX trademark registered in?

The DELIVEREX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 79282940·Reg 6405652·Filed Jan 31, 2020

Owner Evox Therapeutics Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

DELIVEREX (Serial No. 79282940), Registration No. 6405652, is a registered US trademark filed on Jan 31, 2020 by Evox Therapeutics Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

Renewal window: July 06, 2027257 days remaining

Mark Intelligence

DELIVEREX (Reg. #6405652) is a registered US trademark that has been protecting its owner, Evox Therapeutics Limited, since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jan 31, 2020

SERIAL

79282940

REG#

6405652

REGISTERED

Jul 06, 2021

Owner

Applicant

Evox Therapeutics Limited

Entity

Limited (UK / Scandinavian)

Address

Oxford Science Park,, Medawar Centre, 2nd Floor East Building

Country

Attorney

NameBryce J. Maynard

Law firm

Bryce J. Maynard Buchanan Ingersoll & Rooney PC

Address

1737 King Street, Suite 500, 1737 King Street, Alexandria, VA 22314, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJan 31, 2020

Serial Number79282940

Registration No.6405652

Registration DateJul 06, 2021

Status DateJul 06, 2021

Published for OppositionApr 20, 2021

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

37 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jul 06, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

NEW REPRESENTATIVE AT IB RECEIVED

Dec 04, 2021

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 23, 2021

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Nov 01, 2021

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Nov 01, 2021

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 06, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jul 06, 2021

REGISTERED-PRINCIPAL REGISTER

LIMITATION FROM THE IB EXAMINED AND ENTERED

May 04, 2021

LIMITATION FROM THE IB EXAMINED AND ENTERED

LIMITATION OF GOODS RECEIVED FROM IB

May 01, 2021

LIMITATION OF GOODS RECEIVED FROM IB

PUBLISHED FOR OPPOSITION

Apr 20, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 20, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Apr 18, 2021

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 31, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Mar 31, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 31, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

Mar 13, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 13, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 13, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 13, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 13, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

SUSPENSION LETTER WRITTEN

Mar 06, 2021

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Mar 06, 2021

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Mar 06, 2021

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 28, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 28, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Jan 27, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 16, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NEW REPRESENTATIVE AT IB RECEIVED

Jul 30, 2020

NEW REPRESENTATIVE AT IB RECEIVED

REFUSAL PROCESSED BY IB

May 29, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

May 14, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

May 14, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Apr 30, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Apr 29, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 20, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Apr 17, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 13, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 09, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

DELIVEREX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Evox Therapeutics Limited

Other Marks by Bryce J. Maynard

Resources

Company